VOIR TOUS LES INVESTISSEMENTS VOIR TOUS LES INVESTISSEMENTS

Omnicare

Omnicare is a vertically integrated healthcare platform for outpatient oncology care which operates throughout Germany.

Founded in 2002, Omnicare primarily distributes finished medicinal products to highly specialised pharmacies for the patient-specific production of cancer drugs or produces these drugs itself in its own clean room facilities.

Since 2012, the business has expanded its offering by developing additional services for highly specialised pharmacies and medical clinics in quality assurance, monitoring clean room hygiene, as well as training and development of specialist staff. These services were further extended in 2019 through the creation of the Omnicare Quality Initiative, which aims to ensure the safe and high-quality care of oncology patients.

Omnicare has also established the German Oncological Network of leading oncology practices in 2018, which aims to strengthen and further develop oncological practices in the interests of patients.

Headquartered in Unterföhring in Munich, the business has additional sites in Cologne and Calw, supported by 193 employees who provide a service that enables outpatients to more quickly access specialist medicine and services close to where they live.

DATE D’INVESTISSEMENT

oct. 2019

PAYS

Germany

SECTEUR D’ACTIVITE:

Healthcare

Chiffre d'affaires à l'acquisition

€703m

Nombre d'employés à l'acquisition

193

TYPE D’INVESTISSEMENT

Primary MBO

Omnicare 1

With Equistone’s support, we want to continue improving local and outpatient care for cancer patients in Germany.

Opérations de croissance externe

Laborgemeinschaft für Hämatologie und Onkologie - LGHO (DE)
déc. 2021